In this study, the investigators will determine whether patients with elevated levels of LDL
are characterized by specific epigenetic changes in circulating cells of the innate immune
system, compared to control subjects with healthy levels of LDL and whether regular statin
treatment influences these changes.
Details
Lead Sponsor:
Radboud University
Collaborators:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Erasmus Medical Center